BiondVax Pharmaceuticals Ltd. (BVXV) Stock Faltering in Aftermarket, Here’s Why

BVXV Stock

BiondVax Pharmaceuticals Ltd. (BVXV), a biopharmaceutical company, closed Friday’s regular trading session at $1.68 after gaining an increase of 1.20 percentage points. In the aftermarket trading session, however, BVXV stock has shown an abysmal performance. The stock was trading at $1.56 after plunging 7.14% at the last check. The poor performance could be attributed to […]

Invest Headlines
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.